Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of March 2026, with the report dated March 24, 2026. The filing primarily addresses significant changes in executive leadership, specifically the appointment of a new Chief Financial Officer and the resignation of the Vice President of R&D and Engineering.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance data.
Material Changes
- Appointment of CFO: On March 19, 2026, the Company appointed Mr. Meir Peleg as Chief Financial Officer. His employment is scheduled to commence on May 17, 2026. An Employment Agreement was executed on March 19, 2026.
- Resignation of VP R&D: On March 19, 2026, the Company was notified of the resignation of Naum Muchnik, Vice President of R&D and Engineering, effective April 12, 2026. The resignation is stated to be unrelated to any disagreement regarding operations, policies, or practices.
Outlook, Risks, and Management Commentary
Mr. Peleg brings significant experience, having served as CFO of Gauzy Ltd. (NASDAQ: GAUZ) from September 2017 to January 2026, and previously as CFO at F.B.M. Composite Materials Ltd. He also holds a Master's Degree in Business Administration and a Bachelor of Science in Economics and Computer Science. The Company expects to enter into a standard indemnification agreement with Mr. Peleg. No specific financial guidance, risks, or contingencies were disclosed in this filing.
Investor Verification Checklist
- Verify the start date of Mr. Peleg's employment (May 17, 2026) and review the terms of the Employment Agreement.
- Confirm the transition plan for the Vice President of R&D and Engineering role following Mr. Muchnik's departure on April 12, 2026.
- Review the press release (Exhibit 99.1) for additional details on the leadership changes.
- Note that this filing contains no financial data; refer to the most recent Form 20-F or quarterly reports for financial metrics.